Agreement signedPublished 26 Jun 2025

Vyome Therapeutics /
ReShape Lifesciences Inc.

Vyome Therapeutics merger agreement with ReShape Lifesciences Inc. advances toward completion

Buy side: Vyome Therapeutics
Buy sideVyome Therapeutics
Target: ReShape Lifesciences Inc.
TargetReShape Lifesciences Inc.
Source · 26 Jun 2025Source-verified
Buy side: Vyome Therapeutics
Buy sideVyome Therapeutics
Target: ReShape Lifesciences Inc.
TargetReShape Lifesciences Inc.
01 / BuyerVyome Therapeutics
02 / TargetReShape Lifesciences Inc.
Source-verified
01

What happened

ReShape Lifesciences Inc. reported that it is progressing toward finalizing its merger agreement with Vyome Therapeutics. The filing also noted an asset sale to Biorad Medisys and said a shareholder meeting to vote on the transactions is scheduled for July 24, 2025.

ReShape Lifesciences Inc. offers products and services for managing and treating obesity and metabolic disease.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Vyome Therapeutics merger agreement with ReShape Lifesciences Inc. advances toward completion

This document is the source for the companies, stage and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified
  2. Also stated

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.